FNArena Windows
Introduction to FNArena Windows
FNArena Windows offers subscribers the option to investigate ASX-listed stocks against their peers. FNArena developed its own sector methodology which in our view overcomes many flaws and disadvantages connected with GICS sectors. Our system starts with three broad sector labels: COMMODITIES, FINANCIAL SERVICES and INDUSTRIALS. From here onwards subscribers can explore further through gradually narrowing branches. This is not investment advice, but simply another window on the Australian Stock Exchange to provide better insight and to assist FNArena subscribers while conducting their own market analysis.
Latest Stories
FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. Today’s idea is Pro Medicus
Jun 04 2026
Cochlear’s shock downgrade has challenged the long-held assumption the company is immune to economic cycles
Apr 23 2026
| ASX CODE | LAST PRICE | % MOVE | 52WK HIGH | 52WK LOW | P/E | CONSENSUS TARGET | UPSIDE/DOWNSIDE |
|---|---|---|---|---|---|---|---|
| 4DX | $3.68 |
|
$7.55 | $0.23 | -20.3 |
$4.50 |
|
| AT1 | $0.02 | 0.00% | $0.05 | $0.01 |
|
||
| BB1 | $0.64 |
|
$1.11 | $0.41 |
$1.76 |
|
|
| BRN | $0.18 | 0.00% | $0.27 | $0.13 |
|
||
| CAT | $3.08 |
|
$7.72 | $2.86 |
$5.134 |
|
|
| CBL | $0.09 | 0.00% | $0.10 | $0.03 |
|
||
| CGS | $2.74 |
|
$2.97 | $1.35 | 29.9 |
$3.20 |
|
| CMP | $0.24 |
|
$0.45 | $0.24 |
|
||
| COH | $103.75 |
|
$319.56 | $88.74 | 24.6 |
$116.528 |
|
| CSX | $0.40 |
|
$0.88 | $0.32 |
|
||
| CTE | $1.06 | 0.00% | $1.30 | $0.66 |
|
||
| CU6 | $2.15 |
|
$5.87 | $1.97 |
$6.50 |
|
|
| CVB | $0.04 |
|
$0.18 | $0.04 |
|
||
| EBR | $0.38 | 0.00% | $1.48 | $0.37 |
$2.235 |
|
|
| EMV | $1.57 |
|
$2.43 | $1.48 |
$3.15 |
|
|
| EYE | $0.12 |
|
$0.21 | $0.10 |
|
||
| FPH | $32.23 |
|
$35.31 | $26.51 | 40.8 |
|
|
| IME | $0.39 |
|
$0.47 | $0.22 | 18.6 |
$0.50 |
|
| IMR | $1.75 |
|
$2.25 | $1.15 |
$2.61 |
|
|
| IPD | $0.01 | 0.00% | $0.06 | $0.01 |
$0.018 |
|
|
| LDX | $0.11 |
|
$0.33 | $0.03 |
|
||
| MX1 | $0.04 | 0.00% | $0.12 | $0.04 |
$0.15 |
|
|
| NAN | $3.32 | 0.00% | $4.77 | $2.96 | 59.3 |
$3.80 |
|
| ONE | $0.17 |
|
$0.41 | $0.16 |
$0.45 |
|
|
| PCK | $0.13 |
|
$0.35 | $0.03 |
|
||
| PEB | $0.26 |
|
$0.26 | $0.08 |
|
||
| PGC | $0.15 | 0.00% | $0.41 | $0.14 | 11.5 |
$0.25 |
|
| PME | $164.00 |
|
$336.00 | $107.75 | 91.0 |
$218.667 |
|
| RAP | $0.04 | 0.00% | $0.07 | $0.03 |
|
||
| RMD | $27.72 |
|
$45.25 | $25.50 | 16.6 |
$43.643 |
|
| SHG | $0.20 |
|
$0.42 | $0.19 |
|
||
| SOM | $0.53 |
|
$0.95 | $0.50 | 33.1 |
$0.99 |
|
| TRJ | $0.33 |
|
$0.97 | $0.27 | 17.8 |
$0.825 |
|
1.38% 
Previous Stories
GLP-1s Drive Strong Quarter For ResMed
Feb 02 2026
It was once feared weight-loss drugs would crush demand for sleep apnoea products. ResMed’s December quarter has shown very much the opposite is true
ImpediMed Ready To Scale Up
Dec 16 2025
It’s been a long road for medical device manufacturer ImpediMed, but analysts believe the company is now ready to increase scale
Fisher & Paykel Healthcare’s Superior Profile
Dec 02 2025
Fisher & Paykel Healthcare’s first half saw lower costs overcoming a drag from US tariffs. Declining US vaccination rates could provide a boost in the second half
4DMedical Poised For A Recovery
Nov 25 2025
Michael Gable of Fairmont Equities notes 4DMedical shares retraced from a new October high and the bounce supports a move higher
Treasure Chest: Pro Medicus
Nov 12 2025
FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. Today’s idea is Pro Medicus
Tariff Uncertainty Negates ResMed’s Q1 Positives
Nov 05 2025
ResMed’s first-quarter result broadly met market expectations, though rising margins and potential for further capital management have been negated by US import tariff ambiguity
Acquisition Loads Up Catapult
Oct 20 2025
In its latest acquisition, Catapult Sports has added the missing element to make it a globally competitive sports software company
Cochlear’s Future In Nexa’s Hands
Aug 19 2025
Following a weak FY25, and weak FY26 guidance, Cochlear’s outlook rests on the success of its new Nexa implant and other products. Is the market too confident?
ResMed’s New Level Of Support
Jul 29 2025
Michael Gable of Fairmont Equities reports buying the dip remains a valid strategy for ResMed shares above new technical support of $40
Strength To ‘AI’ Strength For Pro Medicus
Jul 10 2025
Pro Medicus shares surge on major contract wins and growing AI momentum, reinforcing its position as a high-margin healthcare tech leader against a background of eternal valuation debate
Latest News
| 1 |
The Market In Numbers – 13 Jun 20269:09 AM - Australia |
| 2 |
ASX Winners And Losers Of Today – 12-06-26Jun 12 2026 - Daily Market Reports |
| 3 |
The Short Report – 12 Jun 2026Jun 12 2026 - Weekly Reports |
| 4 |
In Case You Missed It – BC Extra Upgrades & Downgrades – 12-06-26Jun 12 2026 - Weekly Reports |
| 5 |
Next Week At A Glance – 15-19 Jun 2026Jun 12 2026 - Weekly Reports |